A study found that quercetin's activation of these SIRT1‐dependent signaling pathways modulates the release and functioning of inflammatory cytokines, which reduces neuronal demyelination and suggests quercetin for treating MS and ALS.151. The gene discussed is SIRT1; the disease is amyotrophic lateral sclerosis.